Genus Capital Management’s Stantec STN Stock Holding History

Genus Capital Management’s Portfolio STN Stock Details STN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,075	Closed	-$265K	–	226
2026 Q1	$265K	Sell	3,075 -1,219	-28%	-$115K	0.03%	173
2025 Q4	$406K	Sell	4,294 -59,240	-93%	-$6.1M	0.05%	156
2025 Q3	$6.85M	Sell	63,534 -920	-1%	-$100K	0.8%	37
2025 Q2	$7M	Buy	64,454 +56,505	+711%	+$5.44M	0.89%	34
2025 Q1	$659K	Buy	+7,949	New	+$636K	0.1%	132
2024 Q2	–	Sell	-9,558	Closed	-$779K	–	356
2024 Q1	$794K	Buy	+9,558	New	+$785K	0.1%	147
2023 Q4	–	Sell	-7,985	Closed	-$554K	–	339
2023 Q3	$521K	Buy	7,985 +4,375	+121%	+$291K	0.08%	147
2023 Q2	$236K	Buy	+3,610	New	+$218K	0.03%	182

Other funds holding STN

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Genus Capital Management's STN Position: Q2 2026 in Review

Genus Capital Management sold out of Stantec (STN) in Q2 2026, closing a stake of 3,075 shares — an estimated $265K sold.

Genus Capital Management first reported a position in STN in Q2 2023 and held it in 8 quarters. The position peaked at $7M in Q2 2025. 291 funds tracked by Wall St. Rank hold STN as of Q2 2026.

Genus Capital Management reported no remaining Stantec position as of Q2 2026 after selling out during the quarter.
Genus Capital Management sold 3,075 Stantec shares in Q2 2026, an estimated $265K.
Genus Capital Management first reported a position in Stantec in Q2 2023 and held it in 8 quarters.
Genus Capital Management's Stantec position peaked at $7M in Q2 2025.
291 funds tracked by Wall St. Rank held Stantec as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.